What is Pathware?
Pathware Inc. is at the forefront of enhancing diagnostic accuracy through its proprietary Bioptic technology, which specializes in real-time biopsy quality assessment. The company directly addresses critical challenges faced by pathologists, hospitals, and insurance providers, aiming to reduce the occurrence of inadequate biopsies and the necessity for superfluous surgeries. By optimizing the efficiency of pathology labs, Pathware also targets improvements in billing potential for pathologists and a reduction in the financial strain on healthcare systems, ultimately benefiting patients, providers, and payers alike.
How much funding has Pathware raised?
Pathware has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2022): $7M with participation from UnityPoint Health Ventures, Solas BioVentures, MVolution Partners, and Level Eight Ventures
Key Investors in Pathware
UnityPoint Health Ventures
UnityPoint Health Ventures is an investment arm focused on healthcare innovation, likely seeking to support companies that improve patient care and operational efficiency within health systems.
Solas BioVentures
Solas BioVentures is a venture capital firm specializing in early-stage life sciences investments, including medical devices and digital health, with a founder-centric approach to advancing patient care.
Level Eight Ventures
Level Eight Ventures invests in science-based solutions for the physical world, focusing on early-stage companies with proven technology in sectors like healthcare, aiming to support market strategy and product development.
What's next for Pathware?
The recent major strategic investment signifies a pivotal moment for Pathware, likely enabling the company to accelerate its product development, expand its market reach, and further solidify its position in the diagnostic technology landscape. This capital infusion is expected to fuel advancements in its Bioptic technology and support broader adoption across healthcare institutions, reinforcing its mission to improve patient outcomes and streamline pathology workflows.
See full Pathware company page
